Format

Send to:

Choose Destination
See comment in PubMed Commons below
Gynecol Oncol. 2000 May;77(2):319-20.

Germline BRCA2 mutation in a patient with fallopian tube carcinoma: a case report.

Author information

  • 1Division of Gynecologic Oncology, Center for Human Genetics, Department of Genetics, University Hospitals of Cleveland, Western Reserve University, Ohio 44106, USA.

Abstract

OBJECTIVES:

Fallopian tube carcinoma is similar to ovarian and peritoneal carcinoma with respect to histology, response to chemotherapy, and prognosis. BRCA germline mutations have been commonly reported in ovarian and peritoneal carcinoma but rarely in other gynecologic cancers.

METHODS:

A patient with fallopian tube carcinoma and a family history of ovarian carcinoma underwent genetic counseling and BRCA testing as did her daughter.

RESULTS:

The patient and her daughter were found to have a germline BRCA2 mutation.

CONCLUSION:

Like a family history of ovarian or peritoneal carcinoma, the occurrence of fallopian tube cancer should alert the clinician to the possibility of an abnormality in the breast cancer susceptibility 1 or 2 genes.

Copyright 2000 Academic Press.

PMID:
10785486
[PubMed - indexed for MEDLINE]

LinkOut - more resources

Full Text Sources

Other Literature Sources

PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk